» Articles » PMID: 15507480

AL-amyloidosis is Underdiagnosed in Renal Biopsies

Overview
Date 2004 Oct 28
PMID 15507480
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Renal amyloidosis is associated with a variety of underlying disease processes. Although amyloid is identical in appearance in these diseases, the precursor proteins are different. Immunofluorescence microscopy has been used as the primary tool in the diagnostic evaluation of the underlying cause of renal AL-amyloidosis. The purpose of this study was to document the sensitivity of immunofluorescence microscopy in AL-amyloidosis.

Methods: We reviewed 36 renal biopsies from patients with amyloidosis collected in two medical centres. All biopsies showed characteristic fibrillary deposits of amyloid on electron microscopy and stained positive with Congo red or Thioflavin-T.

Results: Among these 36 patients, immunofluorescence staining for lambda and kappa light chains was negative or equivocal in 14 biopsies. Of these 14 patients, two patients had evidence of AA-amyloidosis. Twelve patients were found subsequently to have a plasma cell dyscrasia or multiple myeloma with monoclonal immunoglobulin and/or free light chains on immunofixation electrophoresis of urine or serum, and with evaluation of the bone marrow. Thus, 12 of 34 patients (35.3%) with proven AL-amyloidosis had negative immunofluorescence staining for kappa and lambda light chains.

Conclusions: The data demonstrated the low sensitivity of immunofluorescence microscopy in the detection of AL-amyloidosis in the kidney and underscore the need to pursue additional diagnostic studies to identify this problem.

Citing Articles

Monoclonal gammopathy of renal significance from the perspective of nephrologists.

Park K, Kwon S Blood Res. 2024; 59(1):28.

PMID: 39133392 PMC: 11319560. DOI: 10.1007/s44313-024-00027-5.


Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes.

Delrue C, Dendooven A, Vandendriessche A, Speeckaert R, De Bruyne S, Speeckaert M Int J Mol Sci. 2024; 25(11).

PMID: 38892061 PMC: 11172584. DOI: 10.3390/ijms25115875.


Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management.

Shafqat A, Elmaleh H, Mushtaq A, Firdous Z, Ashruf O, Mukhopadhyay D J Clin Med. 2024; 13(6).

PMID: 38541968 PMC: 10971215. DOI: 10.3390/jcm13061744.


Diagnosis for Chinese patients with light chain amyloidosis: a scoping review.

Chen M, Liu J, Wang X, Cao X, Gao X, Xu L Ann Med. 2023; 55(1):2227425.

PMID: 37387123 PMC: 10316733. DOI: 10.1080/07853890.2023.2227425.


Immunoglobulin-Negative Fibrillary Glomerulonephritis Masked in Diabetic Nephropathy: A Case Report and Discussion of a Diagnostic Pitfall.

Lerner G, Singer G, Larsen C, Caza T Glomerular Dis. 2023; 2(2):95-99.

PMID: 36751534 PMC: 9670039. DOI: 10.1159/000520071.